dr. abou-alfa on the role of immunotherapy in hcc
Published 7 years ago • 75 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:26
dr. abou-alfa discusses ongoing studies of immunotherapy in hcc
-
1:33
dr. abou-alfa on trials investigating immunotherapy in hcc
-
1:14
dr. abou-alfa on the ongoing impact and role of regorafenib in hcc
-
2:04
dr. abou-alfa on key trends in hcc research
-
1:36
dr. abou-alfa on sequencing challenges in metastatic hcc
-
0:58
dr. abou-alfa on significance of resorce trial for hcc
-
0:46
dr. abou-alfa on ramucirumab as second-line therapy for hepatocellular carcinoma
-
2:50
dr. abou-alfa on progress made in hepatocellular carcinoma
-
2:05
dr. ghassan abou-alfa on second-line regorafenib in hcc
-
1:38
dr. abou-alfa on adjuvant sorafenib for the treatment of hcc (phase iii storm trial)
-
2:18
use of immunotherapy for hcc
-
1:36
dr. abou-alfa discusses new treatment options in hcc
-
1:27
dr. abou-alfa discusses the storm trial in hcc
-
4:01
hepatocellular carcinoma: future role of immunotherapy
-
2:28
dr. abou-alfa discusses results of the celestial trial in advanced hcc
-
1:08
dr. abou-alfa on sequencing agents in the treatment of patients with hcc
-
1:21
dr. abou-alfa on sorafenib plus doxorubicin in patients with hcc
-
1:05
dr. kim on role of frontline immunotherapy in advanced hcc
-
1:15
dr. huey on the importance of patient selection in hcc